semaglutide peptide therapy At-Home Medical Weight Loss Injections Peptide therapy featured on BBC

Lipolysis Stimulation and Lipogenesis Inhibition Studies in rodent models showed that AOD-9604 peptide preferentially triggers fat release from obese adipocytes more than from lean fat cells

Here's what they found at 64 weeks: Average weight loss of 16.6% with full adherence (vs 2.7% with placebo) 13.6% average loss even for people who didnt stick to the full dose 79.2% of participants on the pill lost at least 5% of body weight 63% lost at least 10% 30% lost 20% or more Serious adverse events were less frequent in the semaglutide group (3.9%) than placebo (8.8%) Just to put the numbers into context, 16% for a 100 kg man is 16 kg

Always consult with a qualified healthcare provider to determine if treatment is right for you.

Grozdev 2014